Personal information

Activities

Employment (5)

Boston University School of Medicine: Boston, MA, US

2020-08 to present | PhD Student (Pharmacology and Experimental Therapeutics)
Employment
Source: Self-asserted source
Stanley Goldstein

Biogen Inc: Cambridge, MA, US

2016-09 to 2020-07 | Associate Scientist III (Drug Metabolism and Pharmacokinetics)
Employment
Source: Self-asserted source
Stanley Goldstein

Infinity Pharmaceuticals Inc: Cambridge, MA, US

2013-04 to 2016-07 | Senior Research Associate (Drug Metabolism and Pharmacokinetics)
Employment
Source: Self-asserted source
Stanley Goldstein

Idenix Pharmaceuticals (aquired by Merck in 2014): Cambridge, MA, US

2012-07 to 2013-04 | Bioanalytical Research Assistant (Drug Metabolism and Pharmacokinetics)
Employment
Source: Self-asserted source
Stanley Goldstein

Semprus Biosciences (acquired by Teleflex in 2012): Cambridge, MA, US

2011-04 to 2012-06 (Analytical Sciences and Polymer Characterization)
Employment
Source: Self-asserted source
Stanley Goldstein

Education and qualifications (2)

Boston University School of Medicine: Boston, MA, US

2020-09 to present | PhD (Pharmacology)
Education
Source: Self-asserted source
Stanley Goldstein

Northeastern University: Boston, MA, US

2008-09 to 2013-05 | Bachelor of Science (Biochemistry)
Education
Source: Self-asserted source
Stanley Goldstein

Professional activities (2)

American Society for Mass Spectrometry: Santa Fe, New Mexico, US

2015 to 2020
Membership
Source: Self-asserted source
Stanley Goldstein

American Association of Pharmaceutical Scientists: Arlington, VA, US

2018 to 2019
Membership
Source: Self-asserted source
Stanley Goldstein

Funding (1)

NIGMS T32 Training Grant in Biomolecular Pharmacology

2021-07 to 2022-06 | Grant
National Institute of General Medical Sciences (Bethesda, MD, US)
GRANT_NUMBER:

5T32GM008541-24

Source: Self-asserted source
Stanley Goldstein

Works (6)

Zhx2 is a candidate gene underlying oxymorphone metabolite brain concentration associated with state-dependent oxycodone reward

Journal of Pharmacology and Experimental Therapeutics
2022-06-10 | Journal article
Part of ISSN: 0022-3565
Part of ISSN: 1521-0103
Source: Self-asserted source
Stanley Goldstein

Non-invasive Imaging of Antisense Oligonucleotides in the Brain via In Vivo Click Chemistry

Molecular Imaging and Biology
2022-06-02 | Journal article
Part of ISSN: 1536-1632
Part of ISSN: 1860-2002
Source: Self-asserted source
Stanley Goldstein

Humanized mice reveal a macrophage-enriched gene signature defining human lung tissue protection during SARS-CoV-2 infection

Cell Reports
2022-04 | Journal article
Part of ISSN: 2211-1247
Source: Self-asserted source
Stanley Goldstein

Genetic basis of thermal nociceptive sensitivity and brain weight in a BALB/c reduced complexity cross.

Molecular Pain
2022-01-28 | Journal article
Part of ISSN: 1744-8069
Part of ISSN: 1744-8069
Source: Self-asserted source
Stanley Goldstein

Perspectives on updates, clarifications and controversies in chromatographic assay guidance for bioanalytical method validation from major regulatory agencies and organizations

Biomedical Chromatography
2021-01 | Journal article
Part of ISSN: 0269-3879
Part of ISSN: 1099-0801
Source: Self-asserted source
Stanley Goldstein

Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate

ACS Medicinal Chemistry Letters
2016-09-08 | Journal article
Part of ISSN: 1948-5875
Part of ISSN: 1948-5875
Source: Self-asserted source
Stanley Goldstein